GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study

The role of glucose-stimulated release of GLP-1 in the development of obesity and type 2 diabetes is unclear. We assessed GLP-1 response to oral glucose in a large study population of lean and obese men and women with normal and impaired glucose regulation. Circulating concentrations of glucose, ins...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2015-07, Vol.64 (7), p.2513-2525
Hauptverfasser: Færch, Kristine, Torekov, Signe S, Vistisen, Dorte, Johansen, Nanna B, Witte, Daniel R, Jonsson, Anna, Pedersen, Oluf, Hansen, Torben, Lauritzen, Torsten, Sandbæk, Annelli, Holst, Jens Juul, Jørgensen, Marit E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2525
container_issue 7
container_start_page 2513
container_title Diabetes (New York, N.Y.)
container_volume 64
creator Færch, Kristine
Torekov, Signe S
Vistisen, Dorte
Johansen, Nanna B
Witte, Daniel R
Jonsson, Anna
Pedersen, Oluf
Hansen, Torben
Lauritzen, Torsten
Sandbæk, Annelli
Holst, Jens Juul
Jørgensen, Marit E
description The role of glucose-stimulated release of GLP-1 in the development of obesity and type 2 diabetes is unclear. We assessed GLP-1 response to oral glucose in a large study population of lean and obese men and women with normal and impaired glucose regulation. Circulating concentrations of glucose, insulin, and GLP-1 during an oral glucose tolerance test (OGTT) were analyzed in individuals with normal glucose tolerance (NGT) (n = 774), prediabetes (n = 525), or screen-detected type 2 diabetes (n = 163) who attended the Danish ADDITION-PRO study (n = 1,462). Compared with individuals with NGT, women with prediabetes or type 2 diabetes had 25% lower GLP-1 response to an OGTT, and both men and women with prediabetes or type 2 diabetes had 16-21% lower 120-min GLP-1 concentrations independent of age and obesity. Obese and overweight individuals had up to 20% reduced GLP-1 response to oral glucose compared with normal weight individuals independent of glucose tolerance status. Higher GLP-1 responses were associated with better insulin sensitivity and β-cell function, older age, and lesser degree of obesity. Our findings indicate that a reduction in GLP-1 response to oral glucose occurs prior to the development of type 2 diabetes and obesity, which can have consequences for early prevention strategies for diabetes.
doi_str_mv 10.2337/db14-1751
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1897377128</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1897377128</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-d500c4d07c273d11663e5ec78dc0b23c0b5a8edf813fbb25cc2bda4a82c000713</originalsourceid><addsrcrecordid>eNqFkU1r3EAMhofQ0mzSHvoHykAvCdTtfNiWnVvIplvDUi_ZDfRm5kOmDl57M2ND_D_ygzNu0hx6KQJpJD28MHoJ-cjZVyElfLOaxxGHhB-RBc9lHkkBv96QBWNchHkOx-TE-zvGWBriHTkWSQqQc7Egj6v1JuL0Bv2h7zzSoaelUy1dtaPpQ1_4sLOjQUubjm4c2kZpHNB_oVvjELtoGTozhP1uOiAVdPkKqM7SUqNvhunPu-jqdsRu1tIT3eLDBd39Rnq5XBa7ovwZbW5Kuh1GO70nb2vVevzwUk_J7ffr3dWPaF2uiqvLdWTiGIbIJoyZ2DIwAqTlPE0lJmggs4ZpIUNKVIa2zristRaJMUJbFatMmHAK4PKUnD3rHlx_P6Ifqn3jDbat6rAffcWzHCQAF9n_0TScMwOexgH9_A9614-uCx-ZKZnmkCcQqPNnyrjee4d1dXDNXrmp4qyaXa1mV6vZ1cB-elEc9R7tK_nXRvkEoueZow</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1693697957</pqid></control><display><type>article</type><title>GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Journals@Ovid Complete</source><creator>Færch, Kristine ; Torekov, Signe S ; Vistisen, Dorte ; Johansen, Nanna B ; Witte, Daniel R ; Jonsson, Anna ; Pedersen, Oluf ; Hansen, Torben ; Lauritzen, Torsten ; Sandbæk, Annelli ; Holst, Jens Juul ; Jørgensen, Marit E</creator><creatorcontrib>Færch, Kristine ; Torekov, Signe S ; Vistisen, Dorte ; Johansen, Nanna B ; Witte, Daniel R ; Jonsson, Anna ; Pedersen, Oluf ; Hansen, Torben ; Lauritzen, Torsten ; Sandbæk, Annelli ; Holst, Jens Juul ; Jørgensen, Marit E</creatorcontrib><description>The role of glucose-stimulated release of GLP-1 in the development of obesity and type 2 diabetes is unclear. We assessed GLP-1 response to oral glucose in a large study population of lean and obese men and women with normal and impaired glucose regulation. Circulating concentrations of glucose, insulin, and GLP-1 during an oral glucose tolerance test (OGTT) were analyzed in individuals with normal glucose tolerance (NGT) (n = 774), prediabetes (n = 525), or screen-detected type 2 diabetes (n = 163) who attended the Danish ADDITION-PRO study (n = 1,462). Compared with individuals with NGT, women with prediabetes or type 2 diabetes had 25% lower GLP-1 response to an OGTT, and both men and women with prediabetes or type 2 diabetes had 16-21% lower 120-min GLP-1 concentrations independent of age and obesity. Obese and overweight individuals had up to 20% reduced GLP-1 response to oral glucose compared with normal weight individuals independent of glucose tolerance status. Higher GLP-1 responses were associated with better insulin sensitivity and β-cell function, older age, and lesser degree of obesity. Our findings indicate that a reduction in GLP-1 response to oral glucose occurs prior to the development of type 2 diabetes and obesity, which can have consequences for early prevention strategies for diabetes.</description><identifier>ISSN: 0012-1797</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/db14-1751</identifier><identifier>PMID: 25677912</identifier><identifier>CODEN: DIAEAZ</identifier><language>eng</language><publisher>United States: American Diabetes Association</publisher><subject>Age Factors ; Aged ; Blood Glucose - analysis ; Body Mass Index ; Cells ; Diabetes ; Diabetes Mellitus, Type 2 - metabolism ; Female ; Gender ; Glucagon-Like Peptide 1 - blood ; Glucose ; Glucose Tolerance Test ; Humans ; Insulin ; Insulin - blood ; Male ; Middle Aged ; Obesity ; Obesity - metabolism ; Prediabetic State - metabolism ; Sex Characteristics ; Waist Circumference</subject><ispartof>Diabetes (New York, N.Y.), 2015-07, Vol.64 (7), p.2513-2525</ispartof><rights>2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.</rights><rights>Copyright American Diabetes Association Jul 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-d500c4d07c273d11663e5ec78dc0b23c0b5a8edf813fbb25cc2bda4a82c000713</citedby><cites>FETCH-LOGICAL-c447t-d500c4d07c273d11663e5ec78dc0b23c0b5a8edf813fbb25cc2bda4a82c000713</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,27933,27934</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25677912$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Færch, Kristine</creatorcontrib><creatorcontrib>Torekov, Signe S</creatorcontrib><creatorcontrib>Vistisen, Dorte</creatorcontrib><creatorcontrib>Johansen, Nanna B</creatorcontrib><creatorcontrib>Witte, Daniel R</creatorcontrib><creatorcontrib>Jonsson, Anna</creatorcontrib><creatorcontrib>Pedersen, Oluf</creatorcontrib><creatorcontrib>Hansen, Torben</creatorcontrib><creatorcontrib>Lauritzen, Torsten</creatorcontrib><creatorcontrib>Sandbæk, Annelli</creatorcontrib><creatorcontrib>Holst, Jens Juul</creatorcontrib><creatorcontrib>Jørgensen, Marit E</creatorcontrib><title>GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study</title><title>Diabetes (New York, N.Y.)</title><addtitle>Diabetes</addtitle><description>The role of glucose-stimulated release of GLP-1 in the development of obesity and type 2 diabetes is unclear. We assessed GLP-1 response to oral glucose in a large study population of lean and obese men and women with normal and impaired glucose regulation. Circulating concentrations of glucose, insulin, and GLP-1 during an oral glucose tolerance test (OGTT) were analyzed in individuals with normal glucose tolerance (NGT) (n = 774), prediabetes (n = 525), or screen-detected type 2 diabetes (n = 163) who attended the Danish ADDITION-PRO study (n = 1,462). Compared with individuals with NGT, women with prediabetes or type 2 diabetes had 25% lower GLP-1 response to an OGTT, and both men and women with prediabetes or type 2 diabetes had 16-21% lower 120-min GLP-1 concentrations independent of age and obesity. Obese and overweight individuals had up to 20% reduced GLP-1 response to oral glucose compared with normal weight individuals independent of glucose tolerance status. Higher GLP-1 responses were associated with better insulin sensitivity and β-cell function, older age, and lesser degree of obesity. Our findings indicate that a reduction in GLP-1 response to oral glucose occurs prior to the development of type 2 diabetes and obesity, which can have consequences for early prevention strategies for diabetes.</description><subject>Age Factors</subject><subject>Aged</subject><subject>Blood Glucose - analysis</subject><subject>Body Mass Index</subject><subject>Cells</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 2 - metabolism</subject><subject>Female</subject><subject>Gender</subject><subject>Glucagon-Like Peptide 1 - blood</subject><subject>Glucose</subject><subject>Glucose Tolerance Test</subject><subject>Humans</subject><subject>Insulin</subject><subject>Insulin - blood</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Obesity</subject><subject>Obesity - metabolism</subject><subject>Prediabetic State - metabolism</subject><subject>Sex Characteristics</subject><subject>Waist Circumference</subject><issn>0012-1797</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1r3EAMhofQ0mzSHvoHykAvCdTtfNiWnVvIplvDUi_ZDfRm5kOmDl57M2ND_D_ygzNu0hx6KQJpJD28MHoJ-cjZVyElfLOaxxGHhB-RBc9lHkkBv96QBWNchHkOx-TE-zvGWBriHTkWSQqQc7Egj6v1JuL0Bv2h7zzSoaelUy1dtaPpQ1_4sLOjQUubjm4c2kZpHNB_oVvjELtoGTozhP1uOiAVdPkKqM7SUqNvhunPu-jqdsRu1tIT3eLDBd39Rnq5XBa7ovwZbW5Kuh1GO70nb2vVevzwUk_J7ffr3dWPaF2uiqvLdWTiGIbIJoyZ2DIwAqTlPE0lJmggs4ZpIUNKVIa2zristRaJMUJbFatMmHAK4PKUnD3rHlx_P6Ifqn3jDbat6rAffcWzHCQAF9n_0TScMwOexgH9_A9614-uCx-ZKZnmkCcQqPNnyrjee4d1dXDNXrmp4qyaXa1mV6vZ1cB-elEc9R7tK_nXRvkEoueZow</recordid><startdate>20150701</startdate><enddate>20150701</enddate><creator>Færch, Kristine</creator><creator>Torekov, Signe S</creator><creator>Vistisen, Dorte</creator><creator>Johansen, Nanna B</creator><creator>Witte, Daniel R</creator><creator>Jonsson, Anna</creator><creator>Pedersen, Oluf</creator><creator>Hansen, Torben</creator><creator>Lauritzen, Torsten</creator><creator>Sandbæk, Annelli</creator><creator>Holst, Jens Juul</creator><creator>Jørgensen, Marit E</creator><general>American Diabetes Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>7TS</scope></search><sort><creationdate>20150701</creationdate><title>GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study</title><author>Færch, Kristine ; Torekov, Signe S ; Vistisen, Dorte ; Johansen, Nanna B ; Witte, Daniel R ; Jonsson, Anna ; Pedersen, Oluf ; Hansen, Torben ; Lauritzen, Torsten ; Sandbæk, Annelli ; Holst, Jens Juul ; Jørgensen, Marit E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-d500c4d07c273d11663e5ec78dc0b23c0b5a8edf813fbb25cc2bda4a82c000713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Age Factors</topic><topic>Aged</topic><topic>Blood Glucose - analysis</topic><topic>Body Mass Index</topic><topic>Cells</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 2 - metabolism</topic><topic>Female</topic><topic>Gender</topic><topic>Glucagon-Like Peptide 1 - blood</topic><topic>Glucose</topic><topic>Glucose Tolerance Test</topic><topic>Humans</topic><topic>Insulin</topic><topic>Insulin - blood</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Obesity</topic><topic>Obesity - metabolism</topic><topic>Prediabetic State - metabolism</topic><topic>Sex Characteristics</topic><topic>Waist Circumference</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Færch, Kristine</creatorcontrib><creatorcontrib>Torekov, Signe S</creatorcontrib><creatorcontrib>Vistisen, Dorte</creatorcontrib><creatorcontrib>Johansen, Nanna B</creatorcontrib><creatorcontrib>Witte, Daniel R</creatorcontrib><creatorcontrib>Jonsson, Anna</creatorcontrib><creatorcontrib>Pedersen, Oluf</creatorcontrib><creatorcontrib>Hansen, Torben</creatorcontrib><creatorcontrib>Lauritzen, Torsten</creatorcontrib><creatorcontrib>Sandbæk, Annelli</creatorcontrib><creatorcontrib>Holst, Jens Juul</creatorcontrib><creatorcontrib>Jørgensen, Marit E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>Physical Education Index</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Færch, Kristine</au><au>Torekov, Signe S</au><au>Vistisen, Dorte</au><au>Johansen, Nanna B</au><au>Witte, Daniel R</au><au>Jonsson, Anna</au><au>Pedersen, Oluf</au><au>Hansen, Torben</au><au>Lauritzen, Torsten</au><au>Sandbæk, Annelli</au><au>Holst, Jens Juul</au><au>Jørgensen, Marit E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><addtitle>Diabetes</addtitle><date>2015-07-01</date><risdate>2015</risdate><volume>64</volume><issue>7</issue><spage>2513</spage><epage>2525</epage><pages>2513-2525</pages><issn>0012-1797</issn><eissn>1939-327X</eissn><coden>DIAEAZ</coden><abstract>The role of glucose-stimulated release of GLP-1 in the development of obesity and type 2 diabetes is unclear. We assessed GLP-1 response to oral glucose in a large study population of lean and obese men and women with normal and impaired glucose regulation. Circulating concentrations of glucose, insulin, and GLP-1 during an oral glucose tolerance test (OGTT) were analyzed in individuals with normal glucose tolerance (NGT) (n = 774), prediabetes (n = 525), or screen-detected type 2 diabetes (n = 163) who attended the Danish ADDITION-PRO study (n = 1,462). Compared with individuals with NGT, women with prediabetes or type 2 diabetes had 25% lower GLP-1 response to an OGTT, and both men and women with prediabetes or type 2 diabetes had 16-21% lower 120-min GLP-1 concentrations independent of age and obesity. Obese and overweight individuals had up to 20% reduced GLP-1 response to oral glucose compared with normal weight individuals independent of glucose tolerance status. Higher GLP-1 responses were associated with better insulin sensitivity and β-cell function, older age, and lesser degree of obesity. Our findings indicate that a reduction in GLP-1 response to oral glucose occurs prior to the development of type 2 diabetes and obesity, which can have consequences for early prevention strategies for diabetes.</abstract><cop>United States</cop><pub>American Diabetes Association</pub><pmid>25677912</pmid><doi>10.2337/db14-1751</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0012-1797
ispartof Diabetes (New York, N.Y.), 2015-07, Vol.64 (7), p.2513-2525
issn 0012-1797
1939-327X
language eng
recordid cdi_proquest_miscellaneous_1897377128
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Journals@Ovid Complete
subjects Age Factors
Aged
Blood Glucose - analysis
Body Mass Index
Cells
Diabetes
Diabetes Mellitus, Type 2 - metabolism
Female
Gender
Glucagon-Like Peptide 1 - blood
Glucose
Glucose Tolerance Test
Humans
Insulin
Insulin - blood
Male
Middle Aged
Obesity
Obesity - metabolism
Prediabetic State - metabolism
Sex Characteristics
Waist Circumference
title GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-11-28T23%3A44%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=GLP-1%20Response%20to%20Oral%20Glucose%20Is%20Reduced%20in%20Prediabetes,%20Screen-Detected%20Type%202%20Diabetes,%20and%20Obesity%20and%20Influenced%20by%20Sex:%20The%20ADDITION-PRO%20Study&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=F%C3%A6rch,%20Kristine&rft.date=2015-07-01&rft.volume=64&rft.issue=7&rft.spage=2513&rft.epage=2525&rft.pages=2513-2525&rft.issn=0012-1797&rft.eissn=1939-327X&rft.coden=DIAEAZ&rft_id=info:doi/10.2337/db14-1751&rft_dat=%3Cproquest_cross%3E1897377128%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1693697957&rft_id=info:pmid/25677912&rfr_iscdi=true